Title:
How to treat ototoxicity
Document Type and Number:
Japanese Patent JP6295278
Kind Code:
B2
Abstract:
The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
Inventors:
Guilloerstrop, Pale
Application Number:
JP2015560282A
Publication Date:
March 14, 2018
Filing Date:
February 26, 2014
Export Citation:
Assignee:
Anida Pharma Inc.
International Classes:
A61K31/202; A61P27/16
Domestic Patent References:
| JP2011520808A | ||||
| JP2001501626A | ||||
| JP2009523414A |
Foreign References:
| US20090156673 | ||||
| US20030191064 | ||||
| WO2010095706A1 |
Other References:
Neurochem Res,2010年,Vol.35,p.1944-1947
Prostaglandins, Leukotrienes and Essential Fatty Acids,2010年,Vol.82,p.27-34
Chemistry & Biology,2011年,Vol.18,p.976-987
Prostaglandins, Leukotrienes and Essential Fatty Acids,2010年,Vol.82,p.27-34
Chemistry & Biology,2011年,Vol.18,p.976-987
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto